PulseAGGREGATOR

Gathering headlines…

Pulse Aggregator

Crawls 10,000+ sources around the clock and organizes the noise into verified stories — de-duplicated, bias-scored, and auto-tagged, with blindspot detection, trend analytics, anomaly alerts, translation, and custom digests or RSS. All in one live dashboard.

MedPage Today

healthLean Left

4h ago

Significant Survival Boost With Novel ADCs in Relapsed Small-Cell Lung Cancertranslating…

(MedPage Today) -- Two investigational anti-B7-H3 antibody-drug conjugates (ADCs) significantly improved survival outcomes in patients with relapsed small-cell lung cancer (SCLC), according to a pair of Chinese trials.
In the TAISHAN-302 study...

Factuality

74/100

Political Bias

Lean Left

Ownership

MedPage Digital Media

Country

Unknown

Keywords#Lung Cancer#Relapsed Small-Cell#Small-Cell Lung#ADCs#Survival

Read Original ↗

Significant Survival Boost With Novel ADCs in Relapsed Small-Cell Lung Cancer | Pulse Aggregator